KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Non-Current Assets (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Non-Current Assets for 9 consecutive years, with $9.9 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 5.33% to $9.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.6 billion through Dec 2025, up 1.41% year-over-year, with the annual reading at $9.9 billion for FY2025, 5.33% up from the prior year.
  • Non-Current Assets hit $9.9 billion in Q4 2025 for Elanco Animal Health, down from $10.1 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $13.6 billion in Q1 2021 to a low of $9.4 billion in Q4 2024.
  • Historically, Non-Current Assets has averaged $11.4 billion across 5 years, with a median of $11.4 billion in 2022.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 106.52% in 2021 and later fell 19.69% in 2024.
  • Year by year, Non-Current Assets stood at $13.2 billion in 2021, then fell by 7.51% to $12.2 billion in 2022, then decreased by 10.29% to $11.0 billion in 2023, then dropped by 14.2% to $9.4 billion in 2024, then grew by 5.33% to $9.9 billion in 2025.
  • Business Quant data shows Non-Current Assets for ELAN at $9.9 billion in Q4 2025, $10.1 billion in Q3 2025, and $10.1 billion in Q2 2025.